top of page
VIIV
About:
Juluca is ViiV Healthcare’s first two-drug, once-daily, single-pill regimen that combines the integrase strand transfer inhibitor (INSTI) dolutegravir to treat HIV/AIDS. Triumeq is a once-daily, single-pill, dolutegravir-based regimen containing a booster-free integrase strand transfer inhibitor (INSTI) to treat HIV/AIDS.
Agency / Client:
McCANN Echo / ViiV Healthcare
Job Description:
Graphic Design
Period:
2017 SEP
Created and designed email campaigns, email templates, and website pages for Juluca and Triumeq, developing visually engaging layouts that clearly present clinical data, therapy benefits, and patient support programs. My designs ensured intuitive navigation, consistent branding, and effective digital communication, supporting healthcare professionals in understanding and sharing key product information.
bottom of page